Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset

Acquisition Transforms the Company into a Broader Pharmaceutical Company Spanning Multiple Sectors

Company Announces Corporate Name Change to Underscore Broader Focus

Read more at globenewswire.com